155 related articles for article (PubMed ID: 30692024)
21. α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.
Brücher K; Illarionov B; Held J; Tschan S; Kunfermann A; Pein MK; Bacher A; Gräwert T; Maes L; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2012 Jul; 55(14):6566-75. PubMed ID: 22731758
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098.
Kurz T; Schlüter K; Kaula U; Bergmann B; Walter RD; Geffken D
Bioorg Med Chem; 2006 Aug; 14(15):5121-35. PubMed ID: 16679022
[TBL] [Abstract][Full Text] [Related]
23. Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy.
McKenney ES; Sargent M; Khan H; Uh E; Jackson ER; San Jose G; Couch RD; Dowd CS; van Hoek ML
PLoS One; 2012; 7(10):e38167. PubMed ID: 23077474
[TBL] [Abstract][Full Text] [Related]
24. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.
Dhiman RK; Schaeffer ML; Bailey AM; Testa CA; Scherman H; Crick DC
J Bacteriol; 2005 Dec; 187(24):8395-402. PubMed ID: 16321944
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Antiplasmodial Activity of Novel Fosmidomycin Derivatives and Conjugates with Artemisinin and Aminochloroquinoline.
Palla D; Antoniou AI; Baltas M; Menendez C; Grellier P; Mouray E; Athanassopoulos CM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33096817
[TBL] [Abstract][Full Text] [Related]
26. Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake.
Brown AC; Parish T
BMC Microbiol; 2008 May; 8():78. PubMed ID: 18489786
[TBL] [Abstract][Full Text] [Related]
27. Fosmidomycin for the treatment of malaria.
Wiesner J; Borrmann S; Jomaa H
Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969
[TBL] [Abstract][Full Text] [Related]
28. MEPicides: α,β-unsaturated Fosmidomycin
Wang X; Edwards RL; Ball HS; Heidel KM; Brothers RC; Johnson C; Haymond A; Girma M; Dailey A; Roma JS; Boshoff HI; Osbourn DM; Meyers MJ; Couch RD; Odom John AR; Dowd CS
ACS Infect Dis; 2023 Jul; 9(7):1387-1395. PubMed ID: 37310810
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates.
Haemers T; Wiesner J; Giessmann D; Verbrugghen T; Hillaert U; Ortmann R; Jomaa H; Link A; Schlitzer M; Van Calenbergh S
Bioorg Med Chem; 2008 Mar; 16(6):3361-71. PubMed ID: 18158249
[TBL] [Abstract][Full Text] [Related]
30. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Reichenberg A; Wiesner J; Weidemeyer C; Dreiseidler E; Sanderbrand S; Altincicek B; Beck E; Schlitzer M; Jomaa H
Bioorg Med Chem Lett; 2001 Mar; 11(6):833-5. PubMed ID: 11277531
[TBL] [Abstract][Full Text] [Related]
31. Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC.
Konzuch S; Umeda T; Held J; Hähn S; Brücher K; Lienau C; Behrendt CT; Gräwert T; Bacher A; Illarionov B; Fischer M; Mordmüller B; Tanaka N; Kurz T
J Med Chem; 2014 Nov; 57(21):8827-38. PubMed ID: 25254502
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
[TBL] [Abstract][Full Text] [Related]
33. gamma-Substituted bis(pivaloyloxymethyl)ester analogues of fosmidomycin and FR900098.
Kurz T; Behrendt C; Pein M; Kaula U; Bergmann B; Walter RD
Arch Pharm (Weinheim); 2007 Dec; 340(12):661-6. PubMed ID: 17994605
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
[TBL] [Abstract][Full Text] [Related]
35. Synthetic Fosmidomycin analogues with altered chelating moieties do not inhibit 1-deoxy-d-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum growth in vitro.
Chofor R; Risseeuw MD; Pouyez J; Johny C; Wouters J; Dowd CS; Couch RD; Van Calenbergh S
Molecules; 2014 Feb; 19(2):2571-87. PubMed ID: 24566322
[TBL] [Abstract][Full Text] [Related]
36. N-acylated sulfonamide congeners of fosmidomycin lack any inhibitory activity against DXR.
Gadakh B; Pouyez J; Wouters J; Venkatesham A; Cos P; Van Aerschot A
Bioorg Med Chem Lett; 2015 Apr; 25(7):1577-9. PubMed ID: 25726328
[TBL] [Abstract][Full Text] [Related]
37. Arylmethyl substituted derivatives of Fosmidomycin: synthesis and antimalarial activity.
Schlüter K; Walter RD; Bergmann B; Kurz T
Eur J Med Chem; 2006 Dec; 41(12):1385-97. PubMed ID: 17055117
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
[TBL] [
